CRESCENT BIOPHARMA, INC. - CBIO

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$483.6M

QoQ value delta ($000)

+$197.7M (+69.17%)

Implied price effect (QoQ)

+53.73%

Total shares

26,539,553

QoQ shares delta

+2,423,199 (+10.05%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 63 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
FMR LLC	75,932	4,133,514	0.0%
BVF INC/IL	50,494	2,748,763	1.61%
Fairmount Funds Management LLC	50,478	2,747,866	3.65%
Venrock Adviser, LLC	39,193	2,133,576	1.46%
FCPM III SERVICES B.V.	30,822	1,677,852	4.27%
BALYASNY ASSET MANAGEMENT L.P.	27,739	1,510,033	0.04%
Vestal Point Capital, LP	27,555	1,500,000	0.77%
Opaleye Management Inc.	24,112	1,312,615	3.18%
TANG CAPITAL MANAGEMENT LLC	21,309	1,160,000	1.08%
VANGUARD CAPITAL MANAGEMENT LLC	14,721	801,395	0.0%
Logos Global Management LP	8,863	482,500	0.44%
Deep Track Capital, LP	8,334	453,686	0.14%
Boxer Capital Management, LLC	8,334	453,686	1.09%
RTW INVESTMENTS, LP	6,849	372,856	0.07%
NEXTBio Capital Management LP	6,849	372,856	3.18%
Remedium Capital Partners, LLC	6,636	361,250	2.36%
VANGUARD GROUP INC	6,612	557,506	0.0%
MILLENNIUM MANAGEMENT LLC	5,943	323,553	0.0%
PRICE T ROWE ASSOCIATES INC /MD/	5,577	303,551	0.0%
Point72 Asset Management, L.P.	5,511	300,000	0.01%
Alyeska Investment Group, L.P.	4,849	264,000	0.01%
GOLDMAN SACHS GROUP INC	4,197	228,475	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	3,924	213,635	0.0%
PERCEPTIVE ADVISORS LLC	3,801	206,942	0.07%
MARSHALL WACE, LLP	3,688	200,780	0.0%